Skip to content

Effect Of Abdominal Hypopressive Training On Stress Urinary Incontinence

Effect Of Abdominal Hypopressive Training On Stress Urinary IncontinenceIn Female Athletes

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06599190
Enrollment
50
Registered
2024-09-19
Start date
2024-08-20
Completion date
2024-12-22
Last updated
2025-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Stress Urinary Incontinence

Keywords

stress incontinence, and female athelete

Brief summary

Fifty female athletes suffering from stress incontinence (SUI) will participate in this study. They will be selected from El Zohour Club, New Cairo City.

Detailed description

They will be randomly distributed into 2 groups equal in numbers: Group (A) (Control group) consists of 25 female athletes. They will receive nutritional instructions and pelvic floor muscle exercises three sessions/week for 3 months. Group (B) (Study group) consists of 25 female athletes. They will receive the same treatment for the control group and abdominal hypopressive exercises three sessions/week of 30 mins per week for 3 months. Before data collection, the purpose and procedures will be fully explained to the females. Informed consent will be obtained from each female. Each female will be evaluated following a standard protocol.

Interventions

OTHERpelvic floor exercises, nutritional instructions

They will receive nutritional instructions and pelvic floor muscle exercises three sessions/week for 3 months.

OTHERabdominal hypopressive exercises, pelvic floor exercises, nutritional instructions

consists of 25 female athletes. They will receive the same treatment for the control group and abdominal hypopressive exercises three sessions/week of 30 mins per week for 3 months.

Sponsors

Cairo University
CollaboratorOTHER
Badr University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

single

Intervention model description

They will be randomly distributed into 2 groups equal in numbers: Group (A) (Control group) consists of 25 female athletes. They will receive nutritional instructions and pelvic floor muscle exercises three sessions/week for 3 months. Group (B) (Study group) consists of 25 female athletes. They will receive the same treatment for the control group and abdominal hypopressive exercises three sessions/week of 30 mins per week for 3 months.

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

1. Female athletes suffering from SUI. 2. They will be diagnosed with SUI using bladder stress test. 3. Their ages will range from 14-18 years old. 4. Their body mass index (BMI) will range from 18.5-24.9 kg/m2. 5. They are single females.

Exclusion criteria

The female athlete will be excluded if they had: 1. Urinary tract infection. 2. Family history of genito-urinary tract cancer. 3. Diabetes mellitus.

Design outcomes

Primary

MeasureTime frameDescription
Assessment of urine loss24 hours pad test for12 weeksPad testing will be used to quantify the volume of urine loss by weighing an absorbent pad before and after some type of leakage provocation. The test will start with weighting clean empty pad in grams. Then, it will be used until next time and weighted again. The weight of the used pad will be subtracted from the weight of the empty pad so the net result will determine the amount of leakage.
assesment of pelvic floor muscle contraction and tonning12 weeksThe measurements will be taken in crock-lying position with a full bladder, neutral lumbar spine. The ultrasound transducer will be inserted transversely directly superior to the symphysis pubis, probe is tilted 60 degrees from vertical (Arab, 2010). Every female will perform 3 maximal PFM contractions so that displacement of the bladder wall, because of a PFM contraction, could be measured.

Secondary

MeasureTime frameDescription
Assessment of symptoms and health related quality of life12 weeksThe ICIQ-SF will be used in assessment of each female in both groups. It is used to measure severity and impact of UI on the quality of life in women. The ICIQ-SF is formed of six items of which four main items ask for rating of UI symptoms in the past 4 weeks. A score of zero means no leakage of urine and no affection on quality of life. (Question 1): quantifies the frequency of urinary leaking, (question 2): evaluates the amount of leaking and (question 3): how much the urinary incontinence interferes with everyday life (Hilton and Robinson, 2011). The scores for items 3, 4 and 5 are taken for the final ICIQ-SF score. Items 1 and 2 are demographic and the final item is a self-diagnostic item for the type of UI. ICIQ- SF (range 0-21) is given four scoring categories: slight (1-5), moderate (6-12), severe (13-18) and very severe (19-21).

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026